Details for New Drug Application (NDA): 020625
✉ Email this page to a colleague
The generic ingredient in ALLEGRA is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
Summary for 020625
Tradename: | ALLEGRA |
Applicant: | Chattem Sanofi |
Ingredient: | fexofenadine hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jul 25, 1996 | TE: | RLD: | No |
Expired US Patents for NDA 020625
Complete Access Available with Subscription